Evidence from clinical trial populations suggests low-dose aspirin reduces the risk of colorectal cancer (CRC). Part of this reduction in risk might be due to protection against metastatic disease. | New use of low-dose aspirin and risk of colorectal cancer by stage at diagnosis A nested case control study in UK general practice